510(k) Report

510(k) · Cleared

Recalled · Class III · 2025

Lancing System, Sterile Lancet for Single Use, Lancing Device

K222472510(k) TraditionalCleared Nov 30, 2022106-day reviewClass II21 CFR 878.4850Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Shandong Lianfa Medical Plastic Products Co., Ltd. · QRL Multiple Use Blood Lancet For Single Patient Use Only

Cleared on Nov 30, 2022 as substantially equivalent to K214022 (Roche Diabetes Care, Inc., 2022) after a 106-day review. Its family tree reaches back 2 generations to 1981. It has been recalled once.

Decided
Nov 30, 2022
Review
106 days
Class
Class II
Product code
QRL
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to K810075 (1981). No later device cites it as a predicate yet.

K810075 · Autoclix · Biodynamics Corp. · 1981K214022 · Accu-Chek Softclix Blood Lancing System · Roche Diabetes Care, Inc. · 202219801990200020102020
  1. Root · 2 generations backK810075 AutoclixBiodynamics Corp. · 1981
  2. 1 generation backK214022 Accu-Chek Softclix Blood Lancing SystemRoche Diabetes Care, Inc. · 2022
  3. This deviceK222472 Lancing System, Sterile Lancet for Single Use, Lancing DeviceShandong Lianfa Medical Plastic Products Co., Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K810075AutoclixBiodynamics Corp.1981—
−1K214022Accu-Chek Softclix Blood Lancing SystemRoche Diabetes Care, Inc.2022—
0 (this device)K222472Lancing System, Sterile Lancet for Single Use, Lancing DeviceShandong Lianfa Medical Plastic Products Co., Ltd.2022—
FIG. 1 — Lineage of K222472, 1981–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRL device

  1. #1 K214022 Accu-Chek Softclix Blood Lancing Systemscore 38.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K214022Accu-Chek Softclix Blood Lancing System
Summary page 5
…uct Code: QRK Page 1 of 6 K222472 5 Predicate Device Information: K214022, “Accu-Chek Softclix Blood Lancing System”, manufactured by “Roche Diabetes Care, Inc.” 6 Device Description: “Lancing Sys…
Roche Diabetes Care, Inc.2022—

Also cleared against K214022: 11 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 25, 2025Class IIIZ-0226-2026Error in labelingDue to incorrect/lack of Unique Device Identifier (UDI) codes.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 41 years and passes through 3 companies; a new generation was cleared every 41.0 years on median.
  • None of the 2 ancestors has a recall.
  • 11 other devices also cite its predicate K214022.

How does its category compare?

All QRL devices

QRL Multiple Use Blood Lancet For Single Patient Use Only: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QRL

2in 2025

2022: 172023: 32024: 22025: 22026 (partial year): 3
2007high 17 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRL

155in 2023

2022: 91 days median2023: 155 days median2026 (partial year): 54 days median
2007high 155 (2023) · low 91 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QRL

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QRL

133in 2025

2022: 12023: 32024: 72025: 133
2007high 133 (2025) · low 0 (2007)2025

MAUDE reports naming product code QRL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
2022179101
2023315503
20242—07
20252—1133
20263540—

What is it indicated for?

“Lancing System” consists of “Sterile Lancet for Single Use” and “Lancing Device” The Lancing System is intended for the hygienic collection of capillary blood for testing purposes from the side of a fingertip and from alternative sites, such as the palm, the upper arm, and the forearm. The reusable lancing device is to be used with sterile, single-use lancets, and is to be cleaned and disinfected between each use, and then the lancets are to be disposed…

Read the full statement (148 words)

“Lancing System” consists of “Sterile Lancet for Single Use” and “Lancing Device”

The Lancing System is intended for the hygienic collection of capillary blood for testing purposes from the side of a fingertip and from alternative sites, such as the palm, the upper arm, and the forearm.

The reusable lancing device is to be used with sterile, single-use lancets, and is to be cleaned and disinfected between each use, and then the lancets are to be disposed of.

The lancing device is for use only on a single patient in a home setting. This lancing device is not suitable for use by healthcare professionals with multiple patients in a healthcare setting.

“Sterile Lancet for Single Use” is a single use device indicated for capillary blood sampling. It can be used in conjunction with “Lancing Device” in home settings, or be used standalone in both home and hospital settings.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K222472: Lancing System, Sterile Lancet for Single Use, Lancing Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K222472

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026